Literature DB >> 2492963

Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.

M McMahon1, H M Marsh, R A Rizza.   

Abstract

Basal insulin supplementation has been used as a therapy for patients with non-insulin-dependent diabetes mellitus (NIDDM) who require insulin. To determine whether basal insulin supplementation in addition to lowering postabsorptive plasma glucose concentration also improves the postprandial pattern of glucose disposition, glucose metabolism after ingestion of a solid mixed meal was assessed in obese patients with NIDDM before and after treatment with ultralente and compared with glucose metabolism observed in nondiabetic subjects. Splanchnic uptake of ingested glucose clearance was assessed by including [2-3H]glucose (a tracer that only minimally cycles through glycogen) in a solid mixed meal. Postprandial gluconeogenesis was estimated by measuring the rate of incorporation of carbon dioxide into glucose. Net glucose and lipid oxidation were measured by indirect calorimetry. Both splanchnic uptake of ingested glucose (27 +/- 1 vs. 14 +/- 2 g) and postprandial hepatic glucose release (51 +/- 5 vs. 24 +/- 3 g) were greater (P less than .001) in diabetic than in nondiabetic subjects. Although the percentage of postprandial hepatic glucose release accounted for by glucose synthesis from bicarbonate was similar in the two groups (25 +/- 2 vs. 35 +/- 5%), the absolute rate was greater in the diabetic patients (13 +/- 1 vs. 8 +/- 1 g; P less than .05). Postprandial glucose oxidation and glucose disposal (measured either isotopically or by the forearm-catheterization technique) were similar in both groups. However, total lipid oxidation was increased in the diabetic patients. (P less than .05). Two weeks of basal insulin supplementation lowered fasting glucose concentrations (from 219 +/- 22 to 144 +/- 21 mg/dl; P less than .01) and integrated postprandial glycemic response (from 814 +/- 68 to 621 +/- 72 min.mg.ml-1) but not to normal. Although circulating insulin concentrations were two- to threefold greater (P less than .02) after 3 mo of basal insulin supplementation, the postprandial pattern of glucose metabolism remained essentially the same. Basal insulin supplementation decreased (P less than .05) both splanchnic uptake of ingested glucose and hepatic glucose release. The addition of a preprandial injection of soluble insulin to basal insulin supplementation further suppressed (P less than .05) postprandial hepatic glucose release, thereby further improving postprandial glucose tolerance. These studies indicate that initial splanchnic glucose clearance, hepatic glucose release, and new glucose synthesis, as well as extrahepatic substrate metabolism, are altered in NIDDM after ingestion of a mixed meal.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492963     DOI: 10.2337/diab.38.3.291

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 2.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 3.  Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?

Authors:  J E Gerich
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

4.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 5.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

6.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

7.  Effects of chronic systemic insulin delivery on insulin action in dogs.

Authors:  M Homan; C P Nicholson; H Katz; J Perkins; M Haymond; M Jensen; P Butler; R Rizza
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

8.  Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

Authors:  S Dinneen; A Alzaid; J Miles; R Rizza
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man.

Authors:  L J Gay; P Schneiter; Y Schutz; V Di Vetta; E Jéquier; L Tappy
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

10.  Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Authors:  Ananda Basu; Chiara Dalla Man; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.